1White MF. Irs proteins and the common path to diabetes [ J]. Am J Physiol Endocrinol Metab, 2002,283(3 ) :413-422.
2Rhodes C J, White MF. Molecular insights into insulin action and secretion [J]. Eur J Clin Invest, 2002,32 Suppl 3:3-13.
3Tamemoto H, Kadowaki T, Tobe K, et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 [ J ]. Nature, 1994,372(6502) :182-186.
4Niessen M. On the role of IRS2 in the regulation of functional beta- cell mass [J]. Arch Physiol Biochem, 2006,112(2) : 65-73.
5Fantin VR, Wang Q, Lienhard GE, et al. Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis [ J ]. Am J Physiol Endocrinol Metab, 2000, 278(1) : E127-133.
6Stefan N, Kovacs P, Stumvoll M, et al. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity [J]. Diabetes, 2003,52(6) :1544-1550.
8Wang H, Rissanen J, Miettinen R, et al. New amino acid substitutions in the IRS-2 gene in Finnish and Chinese subjects with late-onset type 2 diabetes [ J ]. Diabetes, 2001,50 ( 8 ) : 1949-1951.
9Kubota N, Tobe K, Terauchi Y, etal. Disruption ofinsulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia [ J ]. Diabetes, 2000,49(11):1880-1889.
1Kadowaki T. Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest, 2000, 106∶459-465.
2Kido Y, Burks D J, Withers D, et al. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J Clin Invest, 2000, 105∶199-205.
3Valverde AM, Kahn CR, Benito M. Insulin signaling in insulin receptor substrate (IRS)-1 deficient brown adipocytes: requirement of IRS-1 for lipid synthesis. Diabetes, 1999,48∶2122-2131.
4Kido Y, Kano H, Whither DJ. Interaction between insulin receptor and IRS proteins in IR/IRS-1+/-and IR/IRS-2+/- mice. Diabetes, 1999,48 (Suppl 1)∶A10.
5Previs SF, Ren JM, White MF, et al. Contrasting effects of IRS1 vs IRS2 gene disruption on carbohydrate and lipid metabolism in vivo. Diabetes, 1999,48(Suppl 1)∶A51.
6Withers DJ, Sanchez Gutierrez J, Towery H, et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature, 1998, 391∶900-904.
7Terauchi Y, Iwamoto K, Tamemoto H, et al. Development of non-insulin-dependent diabetes mellitus in the dauble knockout mice with disruption of insulin receptor substrate-1 and β-cell glucokinase genes: genetic reconstitution of diabetes as a polygenic disease. J Clin Invest, 1997,99∶861-866.
8Kalidas K, Wasson J,Glaser B, et al. Mapping of the human insulin receptor substrate-2 gene, identification of a linked polymorphic marker and linkage analysis on families with type Ⅱ diabetes: no evidence for a major susceptibility role. Diabetologia, 1998, 41∶1389-1391.
9Okazawa K,Yoshimasa Y,Yosuno A, et al.Study of correlation between IRS-2G1057D gene polymorphism and Japanese type 2 diabetes mellitus Type 2 diabetes mellitu. Diabetes,2001,44(Suppl 1)∶S-89.
10Stefan N, Kovacs P, Stumvoll M, et al. Metabolic effects of the Gly1057Asp polymorphism in IRS-2 and interactions with obesity. Diabetes,2003,52∶1544-1550.
1Ludovico O, Pellegrini F, Di Paola R, et al. Heterogeneouseffect of peroxisome proliferator-activated receptor c2 Ala12variant on type 2 diabetes risk[J]. Obesity (Silver Spring), 2007, 15(5): 1076- 1081.
2Nielsen EM, Hansen L, Carstensen B, et al. The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes[J]. Diabetes, 2003, 52: 573-577.
3Grant SF, Thorleifsson G, Reynisdottir I, et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes[l]. Nat Genet, 2006. 38(3): 320-323.
4Ng MC, Tam CH, Lam VK, et al. Replication and identification of novel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese[J]. J Clin Endocrinol Metab, 2007, 92(9): 3733-3737.
5Pound LD, Sarkar SA, Benn inger RK, et al. Deletion of the mouse Slc30a8 gene encoding zinc transporter-8 results in impaired insulin secretion[J]. Biochem J, 2009, 421(3): 371 -376.
6Xiang J, Li XY, XuM, et al. Zinc transporter-8 gene(SLC30A8) is associated with type 2 diabetes in Chinese[J]. J Clin Endocrinol Metab, 2008, 93(10): 4107-4112.
7Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus[J]. Nature Genetics, 2000,26(2): 163-175.
8Elbein SC, Chu W, Ren Q, et al. Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians[J]. J Clin Endocrinol Metab, 2002, Feb, 87(2): 650-654.
9Kadowaki T, Yamauchi T, Kubota N, et al. Adiponectin and adiponectin receptors in obesity-linked insulin resistance[J]. Novartis Found Symp, 2007, 286: 164-176.
